We thank Dr. Vuilleumier for his interest in our review paper on high-density lipoproteins (HDLs) in systemic lupus erythematosus (SLE) and his comments on anti-apolipoprotein A-1 (apoA-1) autoantibodies. Dr. Vuilleumier raises an important point that the prevalence of high anti-apoA-1 IgG levels is not specific to SLE, which we fully agree with. The prevalence of anti-apoA-1 autoantibodies in different disease settings has been summarized in Table 1. Inconsistent results could be attributed to the assay-to-assay differences introduced by different enzyme-linked immunosorbent assay (ELISA) assays and different positivity cut-off values used.

中文翻译：

---

回复。

我们感谢Vuilleumier博士对我们关于系统性红斑狼疮（SLE）中高密度脂蛋白（HDL）的评论论文以及他对抗载脂蛋白A-1（apoA-1）自身抗体的评论的关注。Vuilleumier博士提出了一个重要的观点，即高抗apoA-1 IgG的患病率并非SLE所特有，我们完全同意。表1总结了抗apoA-1自身抗体在不同疾病环境中的流行情况。不一致的结果可能归因于不同酶联免疫吸附测定（ELISA）测定法和不同阳性阳性率法引入的测定间差异。关闭使用的值。